Quadrant Capital Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-28
| Closed | -$2K | – | 2913 |
|
|
2022
Q3 | $2K | Hold |
28
| – | – | ﹤0.01% | 2455 |
|
|
2022
Q2 | $1K | Sell |
28
-25
| -47% | -$893 | ﹤0.01% | 2502 |
|
|
2022
Q1 | $2K | Sell |
53
-4
| -7% | -$151 | ﹤0.01% | 2221 |
|
|
2021
Q4 | $2K | Buy |
57
+29
| +104% | +$1.02K | ﹤0.01% | 2210 |
|
|
2021
Q3 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 2452 |
|
|
2021
Q2 | – | Sell |
-3
| Closed | – | – | 2632 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 2492 |
|
|
2020
Q4 | $0 | Sell |
3
-17
| -85% | – | ﹤0.01% | 2410 |
|
|
2020
Q3 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 2114 |
|
|
2020
Q2 | – | Sell |
-3
| Closed | – | – | 2463 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2320 |
|
|
2019
Q3 | – | Sell |
-347
| Closed | -$18K | – | 2424 |
|
|
2019
Q2 | $18K | Buy |
+347
| New | +$18K | ﹤0.01% | 1670 |
|